Allergy/Asthma News

BOSTON — Targeting asthma remission as the next goal in asthma therapy should be prioritized, according to a presentation at the CHEST Annual Meeting.

BOSTON — Using virtual asthma coaching improved asthma control in poorly controlled patients, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

BOSTON — Physicians should make technology work for them and not be afraid of it, Priya Bansal, MD, said during her presentation on optimizing workflow at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

With the known negative impacts of air pollution on health, especially in patients with respiratory diseases/conditions, lacking local air quality and pollution data can be detrimental to an individual’s well-being.

BOSTON — Encouraging health-seeking behaviors could expedite recovery for patients with allergic rhinitis, according to a poster at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

BOSTON — Community engagement can help stock inhaler programs for underserved rural schools succeed, according to two posters presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

During assessments of episodic memory, processing speed, and inhibition and attention, children with vs. without asthma had poorer scores, according to results published in JAMA Network Open.

The FDA has accepted the resubmission of the supplemental biologics license application for Dupixent to treat chronic spontaneous urticaria in adults and children, Regeneron Pharmaceutical and Sanofi announced in a press release.

Upadacitinib exhibited efficacy and a favorable benefit-risk profile for the long-term treatment of moderate to severe atopic dermatitis in adolescents, according to a study.